The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments-Reference-Cited by-同舟云学术

The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments

Published:2022-07-02 Issue:1 Volume:384 Page:123-132
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Wronska Anetta

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference97 articles.

1. Circulating miRNA levels differ with respect to carotid plaque characteristics and symptom occurrence in patients with carotid artery stenosis and provide information on future cardiovascular events;Badacz;Postepy Kardiol Interwencyjnej,2018

2. MicroRNAs

3. Nanoparticle delivery of miRNA-21 mimic to cardiac macrophages improves myocardial remodeling after myocardial infarction;Bejerano;Nano Lett,2018

4. Diagnostic and prognostic circulating microRNA in acute stroke: a systematic and bioinformatic analysis of current evidence;Bejleri;J Stroke,2021

5. Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research hotspots and trends regarding microRNAs in hypertension: a bibliometric analysis;Clinical and Experimental Hypertension;2024-01-17

2. The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review;International Journal of Molecular Sciences;2024-01-11

3. Moving theJournal of Pharmacology and Experimental TherapeuticsForward to Address the Needs of Our Authors and Editors—Editorial;Journal of Pharmacology and Experimental Therapeutics;2024-01

4. Circulating microRNAs as biomarkers of Chagas cardiomyopathy;Frontiers in Cardiovascular Medicine;2023-12-19

5. OL-FS13 Alleviates Cerebral Ischemia-reperfusion Injury by Inhibiting miR-21-3p Expression;Current Neuropharmacology;2023-12